Institutional Ownership
Neuroone Med Technologies Co
CUSIP 64130M209COM NEWQ1 2026
13D / 13G Filings
13
Schedule 13D/13G on record
Beneficial Filers
8
Distinct reporting persons
Largest Stake
13.6%
Max % of class reported
Institutional Holders
29
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
13 filings · latest Nov 12, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Nov 12, 2025 | Sio Capital Management, LLC | 13G/A | 4.7% | 2.36M | SEC |
| 2 | Aug 14, 2025 | Bleichroeder LP | 13G | 8.0% | 4.00M | SEC |
| 3 | Aug 13, 2025 | Sio Capital Management, LLC | 13G | 7.1% | 3.52M | SEC |
| 4 | May 15, 2025 | Lytton Laurence W | 13G/A | 2.6% | 1.30M | SEC |
| 5 | May 9, 2025 | Awm Investment Company, Inc. | 13G/A | 4.8% | 2.35M | SEC |
| 6 | Feb 14, 2025 | Manchester Explorer, L.P. | 13G/A | 4.9% | 1.58M | SEC |
| 7 | Feb 4, 2025 | Merchant Adventure Fund, L.P. | 13G/A | 13.6% | 4.20M | SEC |
| 8 | Nov 25, 2024 | Lytton Laurence W | 13G/A | 6.6% | 2.06M | SEC |
| 9 | Nov 14, 2024 | Nantahala Capital Management, LLC | 13G/A | 2.6% | 798.8K | SEC |
| 10 | Feb 14, 2024 | Nantahala Capital Management, LLC | 13G | 5.1% | 1.21M | SEC |
3 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Neuroone Med Technologies Co.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Bleichroeder LP | 4.00M | $3.11M |
| 2 | Bard Associates Inc | 1.84M | $1.43M |
| 3 | Perkins Capital Management Inc | 1.47M | $1.14M |
| 4 | Renaissance Technologies LLC | 655.4K | $509.0K |
| 5 | Geode Capital Management, LLC | 615.6K | $478.1K |
| 6 | Sio Capital Management, LLC | 496.6K | $385.6K |
| 7 | Essex Investment Management Co LLC | 262.0K | $203.4K |
| 8 | Northern Trust Corp | 112.1K | $87.1K |
| 9 | Belpointe Asset Management LLC | 75.0K | $58.2K |
| 10 | Legato Capital Management LLC | 61.6K | $47.9K |